Stable Istotope Labelled Lifastuzumab Biosimilar – Anti-SLC34A2 mAb – Research Grade

Reference: PX-TA1334-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Istotope Labelled Lifastuzumab Biosimilar - Anti-SLC34A2 mAb - Research Grade
SourceCAS 1401812-88-1
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsDNIB0600A (conjugate),MNIB2126A (non conjugate)
ReferencePX-TA1334-SIL
Related ProductsPX-P4478
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-SLC34A2[Homo sapiens] (Lifastuzumab) Monoclonal Antibody

Lifastuzumab is investigated for the treatment of Non-Small Cell Lung Cancer (NSCLC) and Platinum Resistant Ovarian Cancer.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Istotope Labelled Lifastuzumab Biosimilar – Anti-SLC34A2 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below